Value = Strategic Fit + Timing (R)
In a recent Industry survey, 20% of business owners polled stated that they will need to recapitalize or sell their business due to COVID-19 economic damages.
Many businesses have experienced ups and downs in the past, from recession to economic warfare. Then came Covid-19, something that none of us has ever experienced before. It is a biological crisis that has evolved into an economic crisis.
What has the impact been on your business?
In the MedTech field, there are businesses for which this crisis has actually created growth. Some of that growth has happened faster than ever imagined and not for the reasons expected.
As the crisis evolves what will it mean for your business?
Unfortunately, some healthcare services have been put “on hold” during this crisis. This has meant a change in revenues and growth forecasts, with some businesses possibly having to lay off workers.
What does a restart mean and how fast can we recover?
If you are considering your options either for your Exit Strategy or for recapitalizing your business, feel free to reach out to us for a complimentary conversation.
Whether you are one of those companies who is experiencing growth or a slowdown, it can be difficult to envision what the landscape will look like after this crisis, and so we invite you to talk to us.
As the world restarts, there are plenty of potential acquirers (both investors and industry strategics) looking for the right opportunities. We have relationships with many of these possible investors / acquirers involved in MedTech and we communicate with them on a regular basis.
We look forward to talking with you. Please feel free to refer a friend if you think this is a fit for them. As our business continues to grow mostly through referrals, we do offer a lead referral fee!
From Three to a Thousand now available online
Our webinar recording of From Three Units to a Thousand with TMD is now available online. Over 1,000 people registered for this event so if you missed it and want to listen to it, click here.
Contributing Advisors
